GlassScriptPhysician profile
Christopher K Tsai
NPI 1457344483
$5,570.69
in general payments reported to CMS, 2019-2025
50 companies · $907 in 2025
The $907 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $557 · 2020: $475 · 2021: $690 · 2022: $834 · 2023: $1,216 · 2024: $891 · 2025: $907.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,759 · Education: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,759.41 |
| Education | $255.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $620.67 | 2019-2024 | Xtandi, Myrbetriq |
| Abbvie INC. | $586.49 | 2019-2025 | Lupron Depot |
| Bayer Healthcare Pharmaceuticals INC. | $470.47 | 2019-2025 | |
| Janssen Biotech, INC. | $400.57 | 2019-2025 | Erleada, Akeega, Balversa |
| Urogen Pharma, INC. | $308.15 | 2021-2025 | Jelmyto |
| Pfizer INC. | $296.79 | 2019-2025 | |
| Coloplast Corp | $277.53 | 2019-2025 | Speedicath, Porges Coloplast |
| Sumitomo Pharma America, INC. | $266.66 | 2023-2025 | Gemtesa, Orgovyx |
| Teleflex LLC | $241.49 | 2021-2025 | Urolift, Barrigel |
| Endo Pharmaceuticals INC. | $211.64 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $187.70 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $175.84 | 2023 | Prolaris, Myrisk |
| Axonics, INC. | $164.06 | 2021-2024 | Axonics |
| Myovant Sciences INC. | $142.10 | 2021-2022 | |
| Telix Pharmaceuticals | $100.31 | 2024-2025 | Illuccix |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Tsai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.